These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25091310)

  • 21. Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case-Control Study.
    Wang KN; Bell JS; Tan ECK; Gilmartin-Thomas JFM; Dooley MJ; Ilomäki J
    Drugs Aging; 2019 Nov; 36(11):1027-1034. PubMed ID: 31485926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.
    Oudit GY; Bakal JA; McAlister FA; Ezekowitz JA
    Eur J Heart Fail; 2011 Nov; 13(11):1211-5. PubMed ID: 21831912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.
    Bakhriansyah M; Souverein PC; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1141-1148. PubMed ID: 28370857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
    Arana A; Johannes CB; McQuay LJ; Varas-Lorenzo C; Fife D; Rothman KJ
    Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.
    Zipursky J; Macdonald EM; Hollands S; Gomes T; Mamdani MM; Paterson JM; Lathia N; Juurlink DN
    PLoS Med; 2014 Sep; 11(9):e1001736. PubMed ID: 25268962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
    Hong SH; Lee EK; Shin JY
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Proton Pump Inhibitor/Histamine-2 Blocker Use and Ocular Toxoplasmosis: Findings from a Large US National Database.
    Conrady CD; Pradeep T; Yu Y; Johnson MW; VanderBeek BL
    Ophthalmol Retina; 2023 Mar; 7(3):261-265. PubMed ID: 36058521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitor use significantly increases the risk of cryptogenic liver abscess: a population-based study.
    Wang YP; Liu CJ; Chen TJ; Lin YT; Fung CP
    Aliment Pharmacol Ther; 2015 Jun; 41(11):1175-81. PubMed ID: 25871643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of proton pump inhibitors and risk of rosacea: A nationwide population-based study.
    Dai YX; Tai YH; Chen CC; Chang YT; Chen TJ; Chen MH
    J Dermatol; 2020 Oct; 47(10):1126-1130. PubMed ID: 32613686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency.
    Lam JR; Schneider JL; Quesenberry CP; Corley DA
    Gastroenterology; 2017 Mar; 152(4):821-829.e1. PubMed ID: 27890768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding.
    Hung TH; Lee HF; Tseng CW; Tsai CC; Tsai CC
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):353-359. PubMed ID: 29551615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case-Control Study.
    Kuo HY; Liang CS; Tsai SJ; Chen TJ; Chu CS; Chen MH
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between Proton Pump Inhibitors and Hearing Impairment: A Nested Case-Control Study.
    Kim SY; Lee CH; Min C; Yoo DM; Choi HG
    Curr Issues Mol Biol; 2021 May; 43(1):142-152. PubMed ID: 34070082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
    Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
    J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of fracture risk between proton pump inhibitors and histamine-2 receptor antagonists in ANCA-associated vasculitis patients: a nested case-control study.
    Miyano S; Michihata N; Sada KE; Uda K; Matsui H; Fushimi K; Nangaku M; Yasunaga H
    Rheumatology (Oxford); 2021 Apr; 60(4):1717-1723. PubMed ID: 33067623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study.
    Peng YC; Lin CL; Yeh HZ; Chang CS; Wu YL; Kao CH
    Medicine (Baltimore); 2016 Apr; 95(15):e3363. PubMed ID: 27082596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.